Please ensure Javascript is enabled for purposes of website accessibility

Tag Archives: novavax

Md. biotech sees good results from respiratory virus vaccine trial

Novavax Inc., a Gaithersburg-based biotechnology company, on Tuesday announced that it had seen positive data from its phase 2 trial of its respiratory syncytial virus F-protein nanoparticle vaccine candidate. There is no approved vaccine for the virus, which is the most common ...

Read More »

Novavax net loss up, revenue down

Novavax Inc., of Gaithersburg, a clinical-stage vaccine company, reported its net loss more than doubled and revenue dropped $2 million for the quarter ended Dec. 31. Novavax posted a net loss of $31.5 million, or 13 cents per share, compared ...

Read More »

Novavax loss increases

Novavax Inc., of Gaithersburg, a biopharmaceutical company focused on creating vaccines, reported higher revenues but an increased loss for the third quarter. Novavax’s net loss was $19.7 million, or 8 cents per share, for the quarter, compared with a net ...

Read More »

Novavax loss, revenue increase

Novavax Inc., of Gaithersburg, a biopharmaceutical company creating vaccines for infectious diseases worldwide, reported an increase in both revenue and net loss for the second quarter. Novavax had a net loss of $17.9 million, or 8 cents per share, for ...

Read More »

Rockville-based Novavax reports larger quarterly loss

Novavax Inc., of Rockville, a drug delivery company developing vaccines aimed at a broad range of infectious diseases worldwide, reported a net loss of $10 million, or 7 cents per diluted share, for the first quarter of 2013, compared to a net loss of $7.3 million, or 6 cents per share, for the year-ago period.

Read More »